Onconova Therapeutics Inc [ONTX] Set for Gains on 0N 1232300 Trials
Onconova Therapeutics Inc [NASDAQ:ONTX] is one of the most interesting stocks to watch today. This follows the company’s announcement that it has initiated a phase 1 clinical trial of ON 123300. The trial will be done in China and will be a partnership with HanX Biopharmaceuticals. ON 123300 is a new small molecule, and double …
Onconova Therapeutics Inc [ONTX] Set for Gains on 0N 1232300 Trials Read More »